Lenacapavir: A Breakthrough HIV Prevention Tool Held Back by Global Funding Cuts
Adapted from reporting by Rachel Schraer, The Independent (Rethinking Global Aid Project) The closest thing we have to an HIV vaccine has finally arrived. Lenacapavir, a long-acting injectable medication that can prevent nearly 100% of HIV infections when administered twice yearly, is being hailed as revolutionary. Yet despite its promise, only a fraction of the people who need it will gain access. The Numbers Behind the Breakthrough The Cost and Access Challenge Why This Matters Globally Anne Aslett, CEO of the Elton John AIDS Foundation, called the rollout “unprecedented,” noting that doses are arriving in Eswatini at the same time as in the U.S., a sharp contrast to the early AIDS crisis, when African nations waited more than a decade for antiretroviral drugs. Still, she warns that funding gaps threaten progress. Vulnerable populations, young women, LGBTQ communities, sex workers, and people who use drugs, are often excluded from prevention services. Without reaching these groups, the epidemic cannot be contained. Innovation in Delivery 🇬🇧 The UK’s Role Mike Podmore, CEO of STOPAIDS, emphasizes that UK contributions are not just charity, they fuel domestic research and innovation. Agencies like Unitaid have invested £250m into UK universities over the past decade, strengthening both global and local HIV responses. The UK has set a goal to end new HIV transmissions by 2030, and expanding access to lenacapavir will be critical to achieving it. The Call to Action Ending HIV is within reach, but only if global leaders step up. Dr. Hill and advocates worldwide are urging wealthy nations to contribute to a proposed $400m fund to expand access without undermining existing HIV programs. This is a pivotal moment: decades of research and advocacy have brought us closer than ever to a cure. But without adequate funding, only 7% of those who need lenacapavir will receive it. What you can do: Together, we can ensure that this breakthrough doesn’t stall at the starting line. Let’s end HIV and make life better for all. Original reporting by Rachel Schraer, The Independent, as part of the “Rethinking Global Aid” project.
